Search Within

David G Pfister

  1. "Biostatistics Service"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (31)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (68)
  2. Department of Medicine (68)
  3. Epidemiology and Biostatistics (68)
  4. Head and Neck Service (68)
  5. Solid Tumor Oncology Division (68)
  6. Surgery (37)

More Groups

People
  1. Eric Sherman (49)
  2. Nancy Lee (34)
  3. Alan Ho (28)
  4. Sofia Haque (24)
  5. Zhigang Zhang (23)
  6. Lara Dunn (22)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (5)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. International Journal of Radiation Oncology, Biology, Physics (15)
  3. Annals of Oncology (4)
  4. Cancer (4)
  5. JCO Oncology Practice (3)
  6. International Journal of Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Elsevier Inc. (16)
  3. Oxford University Press (6)
  4. Wiley Blackwell (5)
  5. John Wiley & Sons (2)
  6. Nature Publishing Group (2)

More Publishers

Results (68)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Ho, A. L.; Sherman, E. J.; Baxi, S. S.; Haque, S.; Ni, A.; Antonescu, C. R.; Katabi, N.; Morris, L. G.; Chan, T. A. T.; Pfister, D. G.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
    Journal Article

    Ho, A. L.; Dunn, L.; Sherman, E. J.; Fury, M. G.; Baxi, S. S.; Chandramohan, R.; Dogan, S.; Morris, L. G. T.; Cullen, G. D.; Haque, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N.; Schoder, H.; Beattie, B.; Lanning, R.; Riaz, N.; McBride, S.; Katabi, N.; Li, D.; Yarusi, B.; Chan, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)
    Journal Article

    Shapiro, L. Q.; Sherman, E. J.; Riaz, N.; Setton, J.; Koutcher, L.; Zhang, Z.; Shi, W.; Fury, M. G.; Wolden, S. L.; Pfister, D. G.; more...
    Oral Oncology (2014)

    Fulltext@MSK | Save
  • Causes of death in long-term survivors of head and neck cancer
    Journal Article

    Baxi, S. S.; Pinheiro, L. C.; Patil, S. M.; Pfister, D. G.; Oeffinger, K. C.; Elkin, E. B.
    Cancer (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
    Journal Article

    Fury, M. G.; Lee, N. Y.; Sherman, E.; Ho, A. L.; Rao, S.; Heguy, A.; Shen, R.; Korte, S.; Lisa, D.; Ganly, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save